Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.520
+0.020 (0.57%)
At close: Nov 6, 2026, 4:00 PM EST
3.510
-0.010 (-0.28%)
Pre-market: Nov 9, 2026, 5:17 AM EST
Recursion Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 18.55 | 7.67 | 6.47 | 35.54 | 5.18 | 19.22 | 14.75 | 4.55 | 26.08 | 14.42 | 13.79 | 10.89 | 10.53 | 11.02 | 12.13 | 13.68 | 13.16 | 7.67 | 5.33 | 2.53 |
Revenue Growth | 258.49% | -60.10% | -56.11% | 681.74% | -80.16% | 33.34% | 6.89% | -58.26% | 147.62% | 30.86% | 13.68% | -20.36% | -19.96% | 43.56% | 127.53% | 439.91% | 419.34% | 201.06% | 108.16% | -5.87% |
Gross Profit Gross Profit Growth | -90.62 | -93.44 | -93.91 | -74.68 | -130.57 | -129.57 | -136.72 | -106.58 | -60.6 | -68.71 | -64.93 | -68.47 | -70.35 | -53.43 | -46.99 | -41.14 | -43.09 | -44.99 | -34.91 | -45.76 |
Operating Income Operating Income Growth | -123.18 | -134.97 | -128.51 | -116.85 | -172.2 | -176.23 | -185.41 | -183.77 | -98.35 | -100.54 | -96.34 | -100.12 | -99.55 | -81.72 | -68.7 | -63.79 | -62.57 | -66.19 | -55.98 | -64.96 |
Net Income Net Income Growth | -119.04 | -131.01 | -117.5 | -108.12 | -162.25 | -171.9 | -202.49 | -178.91 | -95.84 | -97.54 | -91.37 | -93 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 |
Earnings Per Share EPS Growth | -0.22 | -0.25 | -0.22 | -0.21 | -0.36 | -0.41 | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 | -0.38 | -0.34 | -0.31 | -0.35 | -0.38 | -0.33 | -0.38 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Research and Development Agreements Research and Development Agreements Growth | 18.06 | 7.3 | 6.3 | 35.35 | 4.98 | 19.1 | 14.82 | 4.51 | 26.08 | 14.4 | 13.49 | 10.62 | 10.1 | 11.02 | 12.13 | 13.68 | 13.05 | 7.65 | 5.3 | 2.5 |
Grant Grant Growth | 0.5 | 0.37 | 0.17 | 0.19 | 0.19 | 0.12 | -0.07 | 0.04 | - | 0.01 | 0.3 | 0.27 | 0.43 | 0 | - | - | 0.11 | 0.02 | 0.03 | 0.03 |
Revenue (Total) Revenue (Total) Growth | 18.55 | 7.67 | 6.47 | 35.54 | 5.18 | 19.22 | 14.75 | 4.55 | 26.08 | 14.42 | 13.79 | 10.89 | 10.53 | 11.02 | 12.13 | 13.68 | 13.16 | 7.67 | 5.33 | 2.53 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 549.85 | 545.68 | 654.47 | 743.29 | 659.84 | 525.11 | 500.45 | 594.35 | 427.65 | 474.34 | 296.33 | 391.57 | 387.32 | 405.87 | 473.15 | 549.91 | 454.65 | 515.44 | 591.11 | 516.56 |
Total Debt Total Debt Growth | 74.7 | 66.64 | 72.38 | 77.97 | 82.37 | 88.08 | 92.91 | 108.49 | 90.63 | 89.88 | 50.97 | 50.67 | 51.48 | 52.9 | 53.05 | 51.01 | 52.19 | 53.68 | 52.11 | 0.72 |
Net Cash (Debt) Net Cash Growth | 475.15 | 479.05 | 582.1 | 665.33 | 577.46 | 437.04 | 407.54 | 485.86 | 337.02 | 384.47 | 245.35 | 340.89 | 335.85 | 352.97 | 420.09 | 498.91 | 402.46 | 461.75 | 539 | 515.84 |
Net Cash Growth | -17.72% | 9.61% | 42.83% | 36.94% | 71.34% | 13.67% | 66.11% | 42.52% | 0.35% | 8.92% | -41.60% | -31.67% | -16.55% | -23.56% | -22.06% | -3.28% | -30.39% | -25.55% | 167.36% | 106.63% |
Net Cash Per Share Net Cash Per Share Growth | 0.88 | 0.90 | 1.10 | 1.26 | 1.29 | 1.05 | 1.01 | 1.45 | 1.19 | 1.59 | 1.04 | 1.53 | 1.57 | 1.75 | 2.19 | 2.69 | 2.32 | 2.68 | 3.16 | 3.05 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -77.41 | -105.95 | -81.1 | -46.07 | -117.36 | -76.42 | -131.96 | -115.43 | -59.23 | -82.22 | -102.3 | -74.08 | -72.92 | -67.47 | -73.32 | -44.75 | -54.54 | -61.62 | 77.39 | -61.16 |
Capital Expenditures CapEx Growth | -0.41 | -0.04 | -0.26 | -1.24 | -0.24 | -3.15 | -1.83 | -1.3 | -4.56 | -1.18 | -6.65 | -2.07 | -0.75 | -3.97 | -5.18 | -7.98 | -8.26 | -16.48 | -4.34 | -4.46 |
Free Cash Flow Free Cash Flow Growth | -77.81 | -105.99 | -81.36 | -47.32 | -117.6 | -79.57 | -133.79 | -116.73 | -63.79 | -83.4 | -108.95 | -76.14 | -73.67 | -71.44 | -78.49 | -52.73 | -62.8 | -78.1 | 73.05 | -65.62 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | - | - | - | -210.13% | - | - | - | - | -232.33% | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | -663.95% | -1759.69% | -1985.55% | -328.80% | -3327.58% | -916.75% | -1257.46% | -4042.41% | -377.10% | -697.39% | -698.42% | -919.27% | -945.13% | -741.72% | -566.14% | -466.42% | -475.48% | -862.54% | -1049.71% | -2564.55% |
Pretax Margin | -641.50% | -1708.03% | -1886.71% | -304.19% | -3135.27% | -894.23% | -1374.33% | -3935.31% | -366.82% | -680.19% | -668.06% | -891.18% | -883.10% | -696.43% | -538.38% | -420.39% | -459.31% | -854.31% | -1049.67% | -2563.48% |
Profit Margin | -641.63% | -1708.02% | -1815.58% | -304.24% | -3135.32% | -894.23% | -1373.26% | -3935.46% | -367.46% | -676.56% | -662.41% | -853.88% | -883.10% | -696.43% | -538.38% | -420.39% | -459.31% | -854.31% | -1049.67% | -2563.48% |
FCF Margin | -419.43% | -1381.89% | -1257.09% | -133.15% | -2272.52% | -413.92% | -907.35% | -2567.71% | -244.56% | -578.49% | -789.86% | -699.15% | -699.37% | -648.41% | -646.87% | -385.54% | -477.23% | -1017.70% | 1369.70% | -2590.68% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 32.46 | 35.51 | 24.42 | 28.50 | 48.82 | 31.88 | 35.59 | 45.32 | 28.41 | 40.53 | 50.70 | 47.92 | 34.82 | 28.75 | 27.35 | 36.68 | 64.17 | 77.47 | 94.43 | 284.42 |